- Home
- SUPN vs HOG Comparison
SUPN vs HOG Comparison
Compare SUPN & HOG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SUPN
- HOG
- Stock Information
- Founded
- SUPN 2005
- HOG 1903
- Country
- SUPN United States
- HOG United States
- Employees
- SUPN N/A
- HOG N/A
- Industry
- SUPN Biotechnology: Pharmaceutical Preparations
- HOG Motor Vehicles
- Sector
- SUPN Health Care
- HOG Consumer Discretionary
- Exchange
- SUPN Nasdaq
- HOG Nasdaq
- Market Cap
- SUPN 2.6B
- HOG 2.8B
- IPO Year
- SUPN 2012
- HOG N/A
- Fundamental
- Price
- SUPN $44.80
- HOG $29.82
- Analyst Decision
- SUPN Buy
- HOG Buy
- Analyst Count
- SUPN 2
- HOG 7
- Target Price
- SUPN $43.00
- HOG $30.00
- AVG Volume (30 Days)
- SUPN 654.2K
- HOG 1.6M
- Earning Date
- SUPN 11-03-2025
- HOG 10-23-2025
- Dividend Yield
- SUPN N/A
- HOG 2.42%
- EPS Growth
- SUPN 1411.53
- HOG N/A
- EPS
- SUPN 1.14
- HOG 1.93
- Revenue
- SUPN $665,125,000.00
- HOG $4,474,610,000.00
- Revenue This Year
- SUPN $4.84
- HOG N/A
- Revenue Next Year
- SUPN $17.69
- HOG $4.11
- P/E Ratio
- SUPN $38.93
- HOG $15.47
- Revenue Growth
- SUPN 5.55
- HOG N/A
- 52 Week Low
- SUPN $29.16
- HOG $20.45
- 52 Week High
- SUPN $46.79
- HOG $39.93
- Technical
- Relative Strength Index (RSI)
- SUPN 58.16
- HOG 59.11
- Support Level
- SUPN $43.44
- HOG $29.56
- Resistance Level
- SUPN $46.72
- HOG $30.86
- Average True Range (ATR)
- SUPN 1.08
- HOG 0.85
- MACD
- SUPN -0.48
- HOG -0.16
- Stochastic Oscillator
- SUPN 40.60
- HOG 49.47
About SUPN Supernus Pharmaceuticals Inc.
Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.
About HOG Harley-Davidson Inc.
Harley-Davidson is a leading global manufacturer of heavyweight motorcycles across the custom, cruising, and touring segments, as well as related merchandise, parts, and accessories. In recent years, the firm has expanded into the adventure touring market with its Pan America model and into electric with the LiveWire brand. Its captive finance arm, Harley-Davidson Financial Services, provides wholesale financing to dealers and retail financing and insurance brokerage services to customers. Harley captured around 37% of the heavyweight domestic market in 2024.